Cargando…

Rheumatic heart disease in Uganda: predictors of morbidity and mortality one year after presentation

BACKGROUND: Rheumatic heart disease (RHD), the long-term consequence of rheumatic fever, accounts for most cardiovascular morbidity and mortality among young adults in developing countries. However, data on contemporary outcomes from resource constrained areas are limited. METHODS: A prospective coh...

Descripción completa

Detalles Bibliográficos
Autores principales: Okello, Emmy, Longenecker, Chris T., Beaton, Andrea, Kamya, Moses R., Lwabi, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5219796/
https://www.ncbi.nlm.nih.gov/pubmed/28061759
http://dx.doi.org/10.1186/s12872-016-0451-8
_version_ 1782492526144389120
author Okello, Emmy
Longenecker, Chris T.
Beaton, Andrea
Kamya, Moses R.
Lwabi, Peter
author_facet Okello, Emmy
Longenecker, Chris T.
Beaton, Andrea
Kamya, Moses R.
Lwabi, Peter
author_sort Okello, Emmy
collection PubMed
description BACKGROUND: Rheumatic heart disease (RHD), the long-term consequence of rheumatic fever, accounts for most cardiovascular morbidity and mortality among young adults in developing countries. However, data on contemporary outcomes from resource constrained areas are limited. METHODS: A prospective cohort study of participants aged 5–60 years with established RHD was conducted in Kampala, Uganda, in which clinical exam, echocardiography, electrocardiography (ECG), and laboratory evaluation were done every 3 months and every 4-week benzathine penicillin prophylaxis was prescribed. Participants were followed up for 12 months and outcomes and predictors of morbidity and mortality were assessed using Kaplan Meier curves and Cox proportional hazards models. RESULTS: Of 449 subjects, 66.8% (300/449) were females, median age was 30 (interquartile range 20). 73.7% (331/449) had atleast one follow up visit. Among these, 35% (116/331) developed decompensated heart failure and, 63.7% (211/331) developed atrial fibrillation. Heart failure was associated with poor penicillin adherence (OR = 3.3, CI 2–5.4, p = 0.001), and left ventricular end diastolic diameter greater than 55 mm (OR = 3.16, CI 1.73–5.76, p = 0.001). Atrial fibrillation was associated with left atrial diameter >40 mm (OR = 7.5, CI 2.4–9.8, p = 0.001). There were 59 deaths with a 1-year mortality rate of 17.8%. Most deaths occurred within the first three months of presentation. Subjects whose average adherence to benzathine penicillin was <80% had significantly greater mortality (31% vs. 9%, log rank p < 0.001). In multivariate analysis, the risk of death among those with poor penicillin adherence was 3.81 times higher than those with better adherence (HR = 3.81, CI 1.92–7.63, p = 0.001). Other predictors of 1 year mortality included heart failure (HR 8.36, CI 3.28–21.31, p = 0.001) and left ventricular end diastolic diameter greater than 55 mm (HR = 1.93, CI 1.07–3.49, p = 0.02). CONCLUSION: In this study of RHD in Uganda, morbidity and mortality within 1 year of presentation were higher than in recently published from other low and middle income countries. Suboptimal adherence to benzathine penicillin injections was associated with incident heart failure and mortality over 1 year. Future studies should test interventions to improve adherence among patients with advanced disease who are at the highest risk of mortality.
format Online
Article
Text
id pubmed-5219796
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52197962017-01-10 Rheumatic heart disease in Uganda: predictors of morbidity and mortality one year after presentation Okello, Emmy Longenecker, Chris T. Beaton, Andrea Kamya, Moses R. Lwabi, Peter BMC Cardiovasc Disord Research Article BACKGROUND: Rheumatic heart disease (RHD), the long-term consequence of rheumatic fever, accounts for most cardiovascular morbidity and mortality among young adults in developing countries. However, data on contemporary outcomes from resource constrained areas are limited. METHODS: A prospective cohort study of participants aged 5–60 years with established RHD was conducted in Kampala, Uganda, in which clinical exam, echocardiography, electrocardiography (ECG), and laboratory evaluation were done every 3 months and every 4-week benzathine penicillin prophylaxis was prescribed. Participants were followed up for 12 months and outcomes and predictors of morbidity and mortality were assessed using Kaplan Meier curves and Cox proportional hazards models. RESULTS: Of 449 subjects, 66.8% (300/449) were females, median age was 30 (interquartile range 20). 73.7% (331/449) had atleast one follow up visit. Among these, 35% (116/331) developed decompensated heart failure and, 63.7% (211/331) developed atrial fibrillation. Heart failure was associated with poor penicillin adherence (OR = 3.3, CI 2–5.4, p = 0.001), and left ventricular end diastolic diameter greater than 55 mm (OR = 3.16, CI 1.73–5.76, p = 0.001). Atrial fibrillation was associated with left atrial diameter >40 mm (OR = 7.5, CI 2.4–9.8, p = 0.001). There were 59 deaths with a 1-year mortality rate of 17.8%. Most deaths occurred within the first three months of presentation. Subjects whose average adherence to benzathine penicillin was <80% had significantly greater mortality (31% vs. 9%, log rank p < 0.001). In multivariate analysis, the risk of death among those with poor penicillin adherence was 3.81 times higher than those with better adherence (HR = 3.81, CI 1.92–7.63, p = 0.001). Other predictors of 1 year mortality included heart failure (HR 8.36, CI 3.28–21.31, p = 0.001) and left ventricular end diastolic diameter greater than 55 mm (HR = 1.93, CI 1.07–3.49, p = 0.02). CONCLUSION: In this study of RHD in Uganda, morbidity and mortality within 1 year of presentation were higher than in recently published from other low and middle income countries. Suboptimal adherence to benzathine penicillin injections was associated with incident heart failure and mortality over 1 year. Future studies should test interventions to improve adherence among patients with advanced disease who are at the highest risk of mortality. BioMed Central 2017-01-07 /pmc/articles/PMC5219796/ /pubmed/28061759 http://dx.doi.org/10.1186/s12872-016-0451-8 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Okello, Emmy
Longenecker, Chris T.
Beaton, Andrea
Kamya, Moses R.
Lwabi, Peter
Rheumatic heart disease in Uganda: predictors of morbidity and mortality one year after presentation
title Rheumatic heart disease in Uganda: predictors of morbidity and mortality one year after presentation
title_full Rheumatic heart disease in Uganda: predictors of morbidity and mortality one year after presentation
title_fullStr Rheumatic heart disease in Uganda: predictors of morbidity and mortality one year after presentation
title_full_unstemmed Rheumatic heart disease in Uganda: predictors of morbidity and mortality one year after presentation
title_short Rheumatic heart disease in Uganda: predictors of morbidity and mortality one year after presentation
title_sort rheumatic heart disease in uganda: predictors of morbidity and mortality one year after presentation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5219796/
https://www.ncbi.nlm.nih.gov/pubmed/28061759
http://dx.doi.org/10.1186/s12872-016-0451-8
work_keys_str_mv AT okelloemmy rheumaticheartdiseaseinugandapredictorsofmorbidityandmortalityoneyearafterpresentation
AT longeneckerchrist rheumaticheartdiseaseinugandapredictorsofmorbidityandmortalityoneyearafterpresentation
AT beatonandrea rheumaticheartdiseaseinugandapredictorsofmorbidityandmortalityoneyearafterpresentation
AT kamyamosesr rheumaticheartdiseaseinugandapredictorsofmorbidityandmortalityoneyearafterpresentation
AT lwabipeter rheumaticheartdiseaseinugandapredictorsofmorbidityandmortalityoneyearafterpresentation